GGrantIndex
Sort

35,931 grants matching parkinsons

MULTIMODAL MRI TO PREDICT DBS MOTOR AND COGNITIVE OUTCOMES IN PARKINSON’S DISEASE

$666,020
Melanie A Morrison · University Of California, San Francisco · R01 · FY2023 · NS

Targeting the FBXW7/PGC1 Pathway as a Therapeutic Strategy for Parkinson's Disease

$665,971
David K. Simon · Beth Israel Deaconess Medical Center · R01 · FY2024 · NS

BRAIN ORGANOCHLORINE LEVELS AND NEUROPATHOLOGIC FEATURES OF PARKINSON'S DISEASE

$665,955
Pacific Health Research & Education Institute · · FY2013 · Department of Defense

Glial Involvement in REDOX Homeostasis in the Substantia Nigra

$665,920
Rita Marie Cowell · Southern Research Institute · R01 · FY2021 · NS

Function and Pathogenic Mechanism of LRRK2 in Parkinson's Disease

$665,812
Huaibin Cai · National Institute On Aging · ZIA · FY2013 · AG

Individualized Cell Therapy for Parkinson's Disease

$665,779
Su-Chun Zhang · University Of Wisconsin-Madison · R01 · FY2014 · NS

Multi-Targeting Oligonucleotide Therapeutics for Familial and Sporadic Amyotrophic Lateral Sclerosis

$665,737
Jonathan K Watts · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · NS

Multi-Targeting Oligonucleotide Therapeutics for Familial and Sporadic Amyotrophic Lateral Sclerosis

$665,737
Jonathan K Watts · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · NS

Voltage-dependent ion channels controlling firing patterns of central neurons

$665,498
Bruce P Bean · Harvard Medical School · R01 · FY2012 · NS

Regulation of polarity by Sonic hedgehog morphogen signaling

$665,396
Andrew P McMahon · University Of Southern California · R01 · FY2012 · NS

Neural Mechanisms underlying the benefits of Aerobic Exercise in Advanced Parkinson's disease

$665,118
Jay L Alberts · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · AG

Simultaneous PET/phMR studies on interplay of mGlu/dopamine receptors in PD-like neurodegeneration

$665,020
Anna-Liisa Brownell · Massachusetts General Hospital · R01 · FY2024 · NS

Minocycline Immune Effects on SIV CNS Disease

$664,967
M Christine Zink · Johns Hopkins University · R01 · FY2010 · MH

Molecular basis of activation of the orphan nuclear receptor Nurr1

$664,785
Douglas Kojetin · Scripps Florida · R01 · FY2021 · AG

Molecular basis of activation of the orphan nuclear receptor Nurr1

$664,785
Douglas Kojetin · University Of Florida · R01 · FY2022 · AG

Cognitive intervention to improve simple and complex walking

$664,693
Joe Verghese · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AG

Neuromodulation of Brain States

$664,630
Liqun Luo · Stanford University · R01 · FY2019 · NS

Mass Spectrometry Quantitation

$664,399
Jason Williams · National Institute Of Environmental Health Sciences · ZIC · FY2024 · ES

SUMO family Ubiquitin-like Modifiers In Higher Eukaryotes

$664,047
Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD

SV2A PET in Spinal Cord Injury Imaging

$664,037
Zhengxin Cai · Yale University · R01 · FY2025 · NS

Assembling the Genetic Architecture of X-linked Dystonia Parkinsonism

$663,716
Michael E Talkowski · Massachusetts General Hospital · R01 · FY2024 · NS

SUMO family Ubiquitin-like Modifiers In Higher Eukaryotes

$663,662
Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD

Brain and Genetic Predictors of Individual Differences in Pain and Placebo Analgesia

$663,540
Naomi P. Friedman · University Of Colorado · R01 · FY2019 · DA

Cell Type and Regional Vulnerability in Frontotemporal Dementia

$663,462
Sally Temple · Regenerative Research Foundation · R01 · FY2025 · NS

Cell Type and Regional Vulnerability in Frontotemporal Dementia

$663,462
Sally Temple · Regenerative Research Foundation · R01 · FY2024 · NS